AS Latvijas Juras medicinas centrs

UOM.MU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UOM.MU stands at 4.9M. In comparison, FRE.DE has a market cap of 24B. Regarding current trading prices, UOM.MU is priced at €6.15, while FRE.DE trades at €42.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UOM.MU currently has a P/E ratio of 41.00, whereas FRE.DE's P/E ratio is 22.78. In terms of profitability, UOM.MU's ROE is +0.03%, compared to FRE.DE's ROE of +0.02%. Regarding short-term risk, UOM.MU is less volatile compared to FRE.DE. This indicates potentially lower risk in terms of short-term price fluctuations for UOM.MU.

UOM.MU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UOM.MU stands at 4.9M. In comparison, FME.DE has a market cap of 14.2B. Regarding current trading prices, UOM.MU is priced at €6.15, while FME.DE trades at €48.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UOM.MU currently has a P/E ratio of 41.00, whereas FME.DE's P/E ratio is 22.89. In terms of profitability, UOM.MU's ROE is +0.03%, compared to FME.DE's ROE of +0.04%. Regarding short-term risk, UOM.MU is less volatile compared to FME.DE. This indicates potentially lower risk in terms of short-term price fluctuations for UOM.MU.

UOM.MU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UOM.MU stands at 4.9M. In comparison, BZ7A.F has a market cap of 2.7B. Regarding current trading prices, UOM.MU is priced at €6.15, while BZ7A.F trades at €3.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UOM.MU currently has a P/E ratio of 41.00, whereas BZ7A.F's P/E ratio is 14.96. In terms of profitability, UOM.MU's ROE is +0.03%, compared to BZ7A.F's ROE of +0.28%. Regarding short-term risk, UOM.MU and BZ7A.F have similar daily volatility (0.00).

UOM.MU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UOM.MU stands at 4.9M. In comparison, RHK.DE has a market cap of 796.6M. Regarding current trading prices, UOM.MU is priced at €6.15, while RHK.DE trades at €11.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UOM.MU currently has a P/E ratio of 41.00, whereas RHK.DE's P/E ratio is 19.83. In terms of profitability, UOM.MU's ROE is +0.03%, compared to RHK.DE's ROE of +0.03%. Regarding short-term risk, UOM.MU is less volatile compared to RHK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for UOM.MU.

UOM.MU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UOM.MU stands at 4.9M. In comparison, M12.DE has a market cap of 276.8M. Regarding current trading prices, UOM.MU is priced at €6.15, while M12.DE trades at €14.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UOM.MU currently has a P/E ratio of 41.00, whereas M12.DE's P/E ratio is 17.55. In terms of profitability, UOM.MU's ROE is +0.03%, compared to M12.DE's ROE of +0.15%. Regarding short-term risk, UOM.MU is less volatile compared to M12.DE. This indicates potentially lower risk in terms of short-term price fluctuations for UOM.MU.

UOM.MU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UOM.MU stands at 4.9M. In comparison, MED.DE has a market cap of 143.5M. Regarding current trading prices, UOM.MU is priced at €6.15, while MED.DE trades at €3.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UOM.MU currently has a P/E ratio of 41.00, whereas MED.DE's P/E ratio is 5.49. In terms of profitability, UOM.MU's ROE is +0.03%, compared to MED.DE's ROE of +0.12%. Regarding short-term risk, UOM.MU is less volatile compared to MED.DE. This indicates potentially lower risk in terms of short-term price fluctuations for UOM.MU.

UOM.MU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UOM.MU stands at 4.9M. In comparison, LIK.DE has a market cap of 116.7M. Regarding current trading prices, UOM.MU is priced at €6.15, while LIK.DE trades at €398.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UOM.MU currently has a P/E ratio of 41.00, whereas LIK.DE's P/E ratio is 37.48. In terms of profitability, UOM.MU's ROE is +0.03%, compared to LIK.DE's ROE of +0.26%. Regarding short-term risk, UOM.MU is less volatile compared to LIK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for UOM.MU.

UOM.MU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UOM.MU stands at 4.9M. In comparison, V3V.DE has a market cap of 72.9M. Regarding current trading prices, UOM.MU is priced at €6.15, while V3V.DE trades at €4.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UOM.MU currently has a P/E ratio of 41.00, whereas V3V.DE's P/E ratio is -6.06. In terms of profitability, UOM.MU's ROE is +0.03%, compared to V3V.DE's ROE of +0.11%. Regarding short-term risk, UOM.MU is less volatile compared to V3V.DE. This indicates potentially lower risk in terms of short-term price fluctuations for UOM.MU.

UOM.MU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UOM.MU stands at 4.9M. In comparison, MAK.DE has a market cap of 30.4M. Regarding current trading prices, UOM.MU is priced at €6.15, while MAK.DE trades at €1.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UOM.MU currently has a P/E ratio of 41.00, whereas MAK.DE's P/E ratio is -4.39. In terms of profitability, UOM.MU's ROE is +0.03%, compared to MAK.DE's ROE of +0.10%. Regarding short-term risk, UOM.MU is less volatile compared to MAK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for UOM.MU.